Fundraising Fox
Find your path to Stella
Sign up to see every warm intro you have to Stella
- Paths you didn't know you had: your email and LinkedIn already hold routes to Stella. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Stella Xu is Managing Director of Quan Capital, a life sciences venture fund with offices in China and the US, focusing on cross-border value creation and global investments. Before joining Quan, she held R&D leadership roles at Roche, including VP/Site Head of Roche Innovation Center Shanghai, and earlier led healthcare management consulting engagements at McKinsey in the US. She holds a Ph.D. in Immunology from Northwestern University and a B.S. in Biophysics from Peking University.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Investments
Board seats
Armo BioSciencesCentrexion TherapeuticsDesign TherapeuticsHBM Healthcare InvestmentNextCureTempest TherapeuticsTherorna Inc.Zidan Medical
Per the firm's website.
Colleagues at Quan Capital
Frequently asked questions
- Who is Stella Xu?
- Stella Xu is Managing Director of Quan Capital, a life sciences venture fund with offices in China and the US, focusing on cross-border value creation and global investments. Before joining Quan, she held R&D leadership roles at Roche, including VP/Site Head of Roche Innovation Center Shanghai, and earlier led healthcare management consulting engagements at McKinsey in the US. She holds a Ph.D. in Immunology from Northwestern University and a B.S. in Biophysics from Peking University.
- Where does Stella Xu work?
- Stella Xu is Managing Director at Quan Capital.
- What does Stella Xu invest in?
- Stella Xu invests in Biotech, Healthtech.
- What boards does Stella Xu sit on?
- Stella Xu holds tracked board seats at Armo BioSciences, Centrexion Therapeutics, Design Therapeutics, HBM Healthcare Investment, NextCure, Tempest Therapeutics, Therorna Inc., Zidan Medical.
About this profile. Compiled from public sources — Quan Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights